Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Diagnostic test Stories

2013-10-09 04:21:07

HAMBURG, Germany, October 9, 2013 /PRNewswire/ -- Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced a master collaboration agreement with Bayer HealthCare for the development of companion diagnostics for targeted cancer therapies. The partnership pairs Sysmex Inostics' innovative blood-based companion diagnostic solutions with targeted anti-cancer agents developed by Bayer. "We are pleased to partner with Bayer HealthCare, a global company with an...

2013-09-23 20:22:26

TURKU, Finland, September 23, 2013 /PRNewswire/ -- ArcDia Ltd (http://www.arcdia.com). ArcDia International Ltd today announced the expansion of its distributor and service network to cover 18 countries in Europe and Middle-East, twelve of which have been signed during the last four months. mariPOC(R) is a rapid point-of-care diagnostic test to detect nine pathogens from one nasal swap sample in 20 minutes. mariPOC(R) respi test is designed for testing upper and lower...

2013-08-17 23:03:44

i-calQ, LLC announced as finalist in $2.25 million Nokia Sensing XCHALLENGE: Innovative sensing technology makes essential diagnostic tests available anywhere, anytime… using a smartphone. Salt Lake City, UT (PRWEB) August 17, 2013 What is the most important healthcare device of the future? A smartphone, if it’s powered by a new technology developed by award-winning inventor Dr. Joel Ehrenkranz and the team at i-calQ, LLC based in Salt Lake City. Pronounced ‘eye-calc’ as in ‘I...

2013-07-17 08:25:20

TSX: AMF TORONTO, July 17, 2013 /CNW/ - Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that Dr. Neil Cashman, Amorfix Co-founder and Chief Scientific Officer, will be presenting an update of the Company's ALS diagnostic assay at the 24(th) International Symposium on MND/ALS being held in Milan, Italy December 6-8, 2013. "This international conference represents an excellent forum for...

2013-07-02 16:23:32

MADISON, N.J., July 2, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2013 results on Thursday, July 18, 2013 before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company...

2013-06-03 12:27:55

Veteran Diagnostics and Biotech Executive to Lead Global Commercialization IRVINE, Calif. and AMSTERDAM, June 3, 2013 /PRNewswire/ -- Agendia, a leader in molecular cancer diagnostics, today announced the addition of Peter W. Schineller as its Chief Commercial Officer. In this newly created position, Mr. Schineller will lead Agendia's global commercialization activities as it delivers technologies to translate personalized diagnostics into actionable, patient-centered solutions for...

2013-04-25 08:35:04

- Corus CAD is the Only Clinically Validated Gene Expression Test for the Assessment of Obstructive Coronary Artery Disease - PALO ALTO, Calif., April 25, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced it has entered into an agreement granting to Core Diagnostics India the exclusive right to market and sell CardioDx's Corus(®) CAD diagnostic test in India. Corus CAD is a noninvasive blood-based gene expression...

2013-04-09 12:29:40

Based on 14-3-3eta protein biomarker for aiding early RA diagnosis through an exclusive license with Augurex Life Sciences MADISON, N.J., April 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of two new blood tests for aiding the early diagnosis of rheumatoid arthritis (RA), an autoimmune disorder that can cause debilitating joint damage. The lab-developed tests are based on the...

2013-03-26 08:28:57

SINGAPORE, March 26, 2013 /PRNewswire/ -- VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has hired Jason Terrell MD as Head of US Operations. Dr Terrell will initially be responsible for facilitating Volition's entry into the US market, acting as the company's FDA liaison and pursuing and negotiating FDA compliant US clinical trials. Dr Terrell has a strong grounding in both medicine and more specifically in...

2013-03-15 23:01:05

Exploring the latest advancements and technologies in joint fluid analysis. Wynnewood, PA (PRWEB) March 15, 2013 CD Diagnostics announced today that they will be featured in an upcoming episode of Health Heroes. Located in Wynnewood, PA, CD Diagnostics is a leader in joint fluid analysis. The company´s scientific founder, Carl Deirmengian, MD, discovered the existence of unique genetic signatures for joint disease and infection, as indicated by the presence of various biomarkers in...